Arindon, Princess Bella T.
HRN: 23-15-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2024
CEFUROXIME 750MG (VIAL)
02/17/2024
02/23/2024
IV
640mg
Q8
Urti
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes